Correlation Between Marine Products and Rapport Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Marine Products and Rapport Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Marine Products and Rapport Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Marine Products and Rapport Therapeutics, Common, you can compare the effects of market volatilities on Marine Products and Rapport Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Marine Products with a short position of Rapport Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Marine Products and Rapport Therapeutics,.

Diversification Opportunities for Marine Products and Rapport Therapeutics,

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Marine and Rapport is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Marine Products and Rapport Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rapport Therapeutics, and Marine Products is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Marine Products are associated (or correlated) with Rapport Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rapport Therapeutics, has no effect on the direction of Marine Products i.e., Marine Products and Rapport Therapeutics, go up and down completely randomly.

Pair Corralation between Marine Products and Rapport Therapeutics,

Considering the 90-day investment horizon Marine Products is expected to generate 0.28 times more return on investment than Rapport Therapeutics,. However, Marine Products is 3.64 times less risky than Rapport Therapeutics,. It trades about -0.03 of its potential returns per unit of risk. Rapport Therapeutics, Common is currently generating about -0.22 per unit of risk. If you would invest  995.00  in Marine Products on September 12, 2024 and sell it today you would lose (11.00) from holding Marine Products or give up 1.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Marine Products  vs.  Rapport Therapeutics, Common

 Performance 
       Timeline  
Marine Products 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Marine Products are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Marine Products may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Rapport Therapeutics, 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Rapport Therapeutics, Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively abnormal basic indicators, Rapport Therapeutics, reported solid returns over the last few months and may actually be approaching a breakup point.

Marine Products and Rapport Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Marine Products and Rapport Therapeutics,

The main advantage of trading using opposite Marine Products and Rapport Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Marine Products position performs unexpectedly, Rapport Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rapport Therapeutics, will offset losses from the drop in Rapport Therapeutics,'s long position.
The idea behind Marine Products and Rapport Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated